Buprenorphine
Product Images NDC 68071-2592

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 68071-2592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2592 3)

Label for Buprenorphine 8mg tablets by NuCare Pharmaceuticals, Inc. The label states a package of 30 tablets. Each sublingual tablet contains 8.64mg Buprenorphine HCl equivalent to 8mg of Buprenorphine. It is marked Rx Only, with warnings to keep out of reach of children and store at 68-77°F. Manufacturer is Purdue Pharma L.P., Stamford, CT.*

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical structure of Buprenorphine hydrochloride as shown in the image, depicting the molecule's specific atomic and bond arrangement. The image highlights functional groups and molecular configuration characteristic of Buprenorphine HCl.*

FDA Label Image

Image (Buprenorphine 02)

An instructional illustration showing a hand placing a BUPRENORPHINE sublingual tablet under the tongue inside an open mouth. The diagram highlights the correct placement area for the tablet on the lower gum or floor of the mouth.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.